Package 65862-851-30

{"route": ["ORAL"], "spl_id": "44ab9fdc-f741-47c8-9570-8d24b0f0d106", "openfda": {"nui": ["N0000175599", "N0000020026"], "unii": ["742SXX0ICT"], "rxcui": ["402019", "403957", "484814", "757707"], "spl_set_id": ["0345b81b-f946-4dd6-b49d-2a2bdd4c49c9"], "pharm_class_epc": ["Phosphodiesterase 5 Inhibitor [EPC]"], "pharm_class_moa": ["Phosphodiesterase 5 Inhibitors [MoA]"], "manufacturer_name": ["Aurobindo Pharma Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, FILM COATED in 1 BOTTLE (65862-851-30)", "package_ndc": "65862-851-30", "marketing_start_date": "20190326"}, {"sample": false, "description": "2 BLISTER PACK in 1 CARTON (65862-851-32)  / 15 TABLET, FILM COATED in 1 BLISTER PACK", "package_ndc": "65862-851-32", "marketing_start_date": "20190326"}], "brand_name": "Tadalafil", "product_id": "65862-851_44ab9fdc-f741-47c8-9570-8d24b0f0d106", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Phosphodiesterase 5 Inhibitor [EPC]", "Phosphodiesterase 5 Inhibitors [MoA]"], "product_ndc": "65862-851", "generic_name": "Tadalafil", "labeler_name": "Aurobindo Pharma Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Tadalafil", "active_ingredients": [{"name": "TADALAFIL", "strength": "5 mg/1"}], "application_number": "ANDA206285", "marketing_category": "ANDA", "marketing_start_date": "20190326", "listing_expiration_date": "20261231"}